PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Raw and classically processed rhizomes exhibited significant anticonvulsant activity by decreasing the duration of the tonic extensor phase in animal models [PMID:23049196].
Administration in rat models prevented behavioral deficits in ambulation and rearing and restored exploratory activity [PMID:22131703].
In Drosophila melanogaster, hydroalcoholic extracts reduced mortality and improved locomotor function in a dose-dependent manner [PMID:38643931].
Exosome-like nanoparticles (ACENPs) demonstrated cytotoxic effects, reducing cell viability in MCF-7, MDA-MB-231, and MDA-MB-453 cells [PMID:40421230].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 36871902 (2023) — Acorus calamus var. angustatus Besser: Insight into current research on ethnopharmacological use, phytochemistry, pharmacology, toxicology, and pharmacokinetics. · Phytochemistry
- 2.PMID: 29389665 (2018) — Acorus calamus: a bio-reserve of medicinal values. · Journal of basic and clinical physiology and pharmacology
- 3.PMID: 39065505 (2024) — Kazakhstan Has an Unexpected Diversity of Medicinal Plants of the Genus Acorus (Acoraceae) and Could Be a Cradle of the Triploid Species A. calamus. · Plants (Basel, Switzerland)
- 4.PMID: 23049196 (2012) — Anticonvulsant activity of raw and classically processed Vacha (Acorus calamus Linn.) rhizomes. · Ayu
- 5.PMID: 32325895 (2020)